Post job

Clarus Therapeutics's revenue is $1.1 million.

What is Clarus Therapeutics's revenue?

Clarus Therapeutics's annual revenue is $1.1M. Zippia's data science team found the following key financial metrics about Clarus Therapeutics after extensive research and analysis.
  • Clarus Therapeutics has 30 employees, and the revenue per employee ratio is $36,667.
  • Clarus Therapeutics peak revenue was $1.1M in 2024.

On this page

Peak revenue
$1.1M (2025)
Company peak revenue
Revenue / employee
$36,667
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$1.1M (2025)
Company peak revenue
Revenue / employee
$36,667
Company revenue / employee

Clarus Therapeutics financing

Clarus Therapeutics received early financing of $2.5M on 2004-02-01.

SeriesRound sizeDate
Series A$2.5M02/2004
Series C$8M11/2007
Debt Financing$10M01/2013
Series Unknown$31.5M06/2014
Post Ipo Equity$25M09/2021
Post Ipo Equity$15M12/2021

Clarus Therapeutics investors

InvestorsSecurity type
Thomas, McNerney & PartnersSeries A
Thomas, McNerney & PartnersSeries C
H.I.G. Capital, Inc.Series C
Armentum PartnersDebt Financing
C-Bridge CapitalSeries Unknown
H.I.G. Capital, Inc.Post Ipo Equity

Clarus Therapeutics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Clarus Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Clarus Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Clarus Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Clarus Therapeutics. The data presented on this page does not represent the view of Clarus Therapeutics and its employees or that of Zippia.

Clarus Therapeutics may also be known as or be related to Clarus Therapeutics and Clarus Therapeutics Inc.